Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus vs CNI Reduction in Renal Transplant Patients With Prostate Cancer
NCT00922129Phase 3Withdrawn
- Sponsor
- St. Joseph's Healthcare Hamilton
- Start
- Sep 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in prostate cancer (PCa), sponsored by St. Joseph's Healthcare Hamilton. Planned start Sep 2009; status: withdrawn.
02
Drugs
sirolimus
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00922129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00922129.